Menu

Evidence section

Lifestyle programs, dietitians and diabetes prevention

Reviewed and signedLast updated 2026-09-18Reviewed by two pharmacists registered in British Columbia, 2026-09-18

Two pharmacists registered and practising in British Columbia read this page against the study pages and papers it lists and signed it. Their names are withheld from the site and held on file; their registration is confirmed on request.

Medicines are only part of weight management. This hub covers the large studies of structured lifestyle programs: the Diabetes Prevention Program and its twenty-year follow-up, Look AHEAD in people with type 2 diabetes, DiRECT and DIADEM-I on diabetes remission with low-calorie diets, and reviews of dietitian-led care and behavioural programs. Many of these studies are publicly funded and run for longer than any medicine trial.

Studies in this section (13)

Diabetes Prevention Program: lifestyle change versus metformin

The 2002 Diabetes Prevention Program found lifestyle change cut new type 2 diabetes by 58% and metformin by 31% over 2.8 years. A Canadian explainer.

2002Reviewed and signed

Look AHEAD at one year: lifestyle support in type 2 diabetes

Look AHEAD one-year results explained for Canadian readers: intensive lifestyle support and weight loss in adults with type 2 diabetes.

2007Reviewed and signed

Look AHEAD at four years: weight, fitness and heart risk factors

Look AHEAD four-year results for Canadian readers: average weight loss, fitness and heart risk factors with intensive lifestyle support in type 2 diabetes.

2010Reviewed and signed

Can weight-loss surgery prevent type 2 diabetes? The SOS study

The Swedish Obese Subjects study on bariatric surgery and type 2 diabetes prevention, explained in plain language for Canadian readers, with its limits.

2012Reviewed and signed

Look AHEAD at eight years: how much weight stayed off?

Look AHEAD eight-year results for Canadian readers: 4.7% average weight loss with intensive lifestyle support versus 2.1% with education in diabetes.

2014Reviewed and signed

Diabetes Prevention Program: what 15 years of follow-up showed

The Diabetes Prevention Program 15-year follow-up explained for Canadian readers: lifestyle change and metformin still lowered new diabetes, with limits.

2015Reviewed and signed

DiRECT trial: can type 2 diabetes go into remission in one year?

The DiRECT trial explained for Canadian readers: 46% of adults on a primary-care weight-management program reached type 2 diabetes remission at one year.

2018Reviewed and signed

What a large evidence review found about weight-loss programs

A 2018 review of 122 trials found behavioural weight-loss programs led to 2.39 kg more weight loss than control. Explained for Canadian readers.

2018Reviewed and signed

DiRECT at two years: did type 2 diabetes remission last?

DiRECT two-year results explained for Canadian readers: 36% of adults on a primary-care weight-management program were still in type 2 diabetes remission.

2019Reviewed and signed

DIADEM-I: intensive lifestyle change in early type 2 diabetes

DIADEM-I explained for Canadian readers: younger adults with early type 2 diabetes lost 11.98 kg with intensive lifestyle support; 61% reached remission.

2020Reviewed and signed

Diabetes Prevention Program: heart outcomes after 21 years

After 21 years, the Diabetes Prevention Program found no fewer heart attacks or strokes with lifestyle change or metformin. Explained for Canadians.

2022Reviewed and signed

Does seeing a dietitian help with weight? A review of 62 trials

A review of 62 randomized trials found dietitian-led weight management led to 4.01% more weight loss than usual care. Explained for Canadian readers.

2023Reviewed and signed

What role did dietitians play in GLP-1 weight-loss trials?

A 2025 review asked how dietitians were involved in GLP-1 weight-loss trials and found the support poorly described. Explained for Canadian readers.

2025Reviewed and signed

Other evidence sections

Semaglutide studies explainedTirzepatide studies explainedEmerging weight-management medicinesLiraglutide, naltrexone-bupropion and orlistat studiesSetmelanotide and rare genetic obesityWhat happens when weight-management medicines are stoppedBariatric surgery studiesSide effects and safety studiesGLP-1 medicines and pregnancyHow people use GLP-1 medicines outside trialsCanadian guidelines and cost studiesEating disorders and behavioural weight management

How to read these pages

Every page in this section explains one published study. The numbers are reported as the researchers published them, with a link to the paper on PubMed. Pages say what a study cannot tell you and never rank one medicine against another. They are education, not medical advice. For how a medicine is used and paid for in Canada, see medicines, public drug coverage by province and compare services.

Reviewed and signed by two pharmacists registered in British Columbia, 2026-09-18.